
cancer impacts us all
We create solutions to some of the toughest realities facing cancer care today.
OLEA
oncology literacy equity & access

The OLEA Alliance is a national accelerator which convenes researchers, patient advocacy organizations and communities to co-create digital interventions designed to measurably improve the ability for people and their loved ones to face cancer.
Powered by RabbleHealth, we leverage a robust partnership model and implementation science to co-create, build, deploy, and measure effective patient solutions to improve equity, shared decision-making and trial enrollment in the cancer setting.
literacy
optimize the distribution and relevancy of content to
enhance shared decision-making
equity
address social determinants of health by improving
access to services for specific subpopulations
access
support scalability of resources and
clinical research, enabling hope for future patients
In the news
initiative portfolio pipeline
last updated SEP 2023
-
Addressing Breast Cancer Disparities in Memphis TN
Category: Equity
Impact: ~300 people
Subpopulation: Breast cancer (all stages)
Geographical footprint: Memphis Statistical Area (TN, MS, AR)
Status: currently accepting sponsorships
Objectives:
1. Leverage human centered design to improve access to locally-available breast cancer services in communities that are traditionally underserved within the Memphis Statistical Area2. Measure public health impact against root causes of breast inequities (i.e. care pathway metrics) and create a model to scale more broadly
-
Addressing Breast Cancer Disparities in select US cities nationwide
Category: Equity
Impact: ~3,000 people
Subpopulation: Breast cancer (all stages)
Geographical footprint: Atlanta, Chicago, Dallas, Houston, Los Angeles, Philadelphia, St. Louis, Tidewater, Washington DC
Status: creating working group
Objectives:
1. Leverage human centered design to improve access to locally-available breast cancer services in underserved communities throughout the US2. Measure public health impact against root causes of breast inequities (i.e. care pathway metrics) and create a model to scale more broadly
-
Meaningful Diagnostics, Access, & Literacy support | Lung
Category: Literacy
Impact: 250 people
About 238,340 new cases of lung cancer (117,550 in men and 120,790 in women) click here
Subpopulation: Lung cancer (all settings)
Geographical footprint: United States
Status: create working group
Objectives:
1. improve the frequency of lung cancer patients asking for biomarker testing through a tailored and co-created digital literacy intervention2. assess impact of biomarker literacy program on loved ones of patients
-
Meaningful Diagnostics, Access, & Literacy support | Colorectal Cancer
Category: Literacy
Impact: 250 people
Subpopulation: Colorectal cancer (all settings)
Geographical footprint: United States
Status: create working group
Objectives:
1. improve the frequency of colorectal cancer patients asking for biomarker testing through a tailored and co-created digital literacy intervention
2. assess impact of biomarker literacy program on loved ones of patients
-
Meaningful Diagnostics, Access, & Literacy support | Breast
Category: Literacy
Impact: 250 people
Subpopulation: Breast Cancer (metastatic setting)
Geographical footprint: United States
Status: create working group
Objectives:
1. improve the frequency of metastatic breast cancer patients asking for biomarker testing through a tailored and co-created digital literacy intervention
2. assess impact of biomarker literacy program on loved ones of patients
-
Accelerating Community Trials for people facing breast cancer
Category: Access
Impact: ~500 people
Subpopulation: Breast cancer (all stages)
Geographical footprint: the Greater Los Angeles Area, Chicago, Atlanta, and Phoenix
Status: create working group
Objectives:
1. to improve clinical trial recruitment in community centers by supporting individuals newly diagnosed with breast cancer through a community-accessible co-created digital intervention designed to improve the end-to-end clinical trial patient learning journey
2. to improve diversity metrics for breast cancer clinical trials
Join the OLEA Alliance
The OLEA Alliance is open to all members of the healthcare ecosystem who are committed to creating transformational change for those facing cancer.
There are no membership fees to join OLEA. We are committed to working together to establish systematic change through OLEA initiatives.
We look forward to hearing from you.
